Regor Therapeutics is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform. The company focuses mainly on three therapeutic areas, oncology, immunology, and metabolic disorders. By seamlessly integrating CARD with structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development, Regor has successfully assembled a world-class scientific team and established a highly efficient new drug innovation engine to enable the discovery and development of best- and first-in-class molecules.
Company Details
- Employees
- 33
- Founded
- -
- Address
- Building #10, 1206 Zhangjiang Road, Pudong, Shanghai,201203,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.regor.com
- Keywords
- Manager jobs.
- HQ
- Shanghai
Regor Therapeutics Group Questions
Regor Therapeutics Group's website is http://www.regor.com
Regor Therapeutics Group's LinkedIn profile is https://www.linkedin.com/company/regor-therapeutics-group
Regor Therapeutics Group has
33 employees.
View email and phone details for 33
employees at Regor Therapeutics Group.
Regor Therapeutics Group's industry is
Pharmaceutical Manufacturing
Regor Therapeutics Group's top competitors are
Trevena, Inc.,
Septerna,
Eagle Pharmaceuticals, Inc.,
Curon Biopharmaceutical,
Aktis Oncology,
Editas Medicine,
Triveni Bio,
Kailera Therapeutics,
Azurbio Pharma,
Jiangsu Hansoh Pharmaceutical Group Co., Ltd..
Regor Therapeutics Group's categories are Pharmaceutical Manufacturing
Regor Therapeutics Group's founding year is 2018
